Page last updated: 2024-11-05

2,5-pyridinedicarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,5-Pyridinedicarboxylic acid (PDA) is a heterocyclic dicarboxylic acid derived from pyridine. It is a white, crystalline solid with a melting point of 246-248 °C. PDA has been synthesized through various methods, including oxidation of 2,5-dimethylpyridine using potassium permanganate or chromic acid. PDA exhibits diverse biological activities, including antibacterial, antifungal, and antitumor properties. It has also shown potential as a corrosion inhibitor for metals. Its importance lies in its versatility as a building block for various organic compounds and its potential applications in pharmaceuticals, agrochemicals, and material science. Research on PDA focuses on its synthesis, characterization, and biological activities. The compound's ability to form coordination complexes with metal ions has also been investigated, revealing its potential in catalysis and materials science.'

2,5-Pyridinedicarboxylic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

isocinchomeronic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7493
CHEMBL ID88972
CHEBI ID46865
SCHEMBL ID70231
MeSH IDM0446155

Synonyms (50)

Synonym
pyridine carboxylate, 6b
bdbm26114
chembl88972 ,
inchi=1/c7h5no4/c9-6(10)4-1-2-5(7(11)12)8-3-4/h1-3h,(h,9,10)(h,11,12
100-26-5
nsc-177
2,5-pyridinedicarboxylic acid
isocinchomeronic acid
nsc177
pyridine-2,5-dicarboxylic acid
2,5-pyridinedicarboxylic acid, 98%
pyridinedicarboxylic acid-(2,5)
CHEBI:46865 ,
P0552
AKOS000119637
pyridine 2,5-dicarboxylate
4k1kgr926x ,
nsc 177
ai3-19238
unii-4k1kgr926x
einecs 202-834-2
BBL011510
FT-0674191
STL146625
FT-0610502
AM20050593
SCHEMBL70231
AB00376873-03
FG-0457
pyridinedicarboxylic acid [inci]
isocinchomeronic acid [mi]
6-carboxy-nicotinic acid
2,5-dicarboxy-pyridine
pyridine 2,5-dicarboxylic acid
DTXSID3059210
W-204355
mfcd00006297
F0001-0013
NCGC00336418-01
FT-0674190
FT-0674189
Q27120714
EN300-19702
pyridine-2,5-dicarboxylic acid; 2,5-pyridinedicarboxylic acid; 2,5-dicarboxypyridine; isocinchomeronic acid; nsc 177; nicotinic acid impurity d
SY007555
CS-W013239
r3k ,
pyridine-2,5-dicarboxylicacid
HY-W012523
Z104474820
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridinedicarboxylic acidAny member of the class of pyridines carrying two carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Lysine-specific demethylase 4EHomo sapiens (human)IC50 (µMol)180.00000.20001.95696.3096AID1798635
Prolyl 4-hydroxylase subunit alpha-1Homo sapiens (human)Ki2.60002.60002.60002.6000AID1230196
Prolyl 4-hydroxylase subunit alpha-1Rattus norvegicus (Norway rat)IC50 (µMol)5.18002.89004.03505.1800AID160198
Prolyl 4-hydroxylase subunit alpha-1Rattus norvegicus (Norway rat)Ki0.80000.54000.67000.8000AID160202
Beta-lactamase Aeromonas hydrophilaKi420.00004.50005.10005.7000AID323626
Prolyl hydroxylase EGLN2Homo sapiens (human)Ki300.00007.00007.00007.0000AID344923
Egl nine homolog 1Homo sapiens (human)Ki300.00007.00007.66678.0000AID344914
Prolyl hydroxylase EGLN3Homo sapiens (human)Ki300.00007.00007.00007.0000AID344924
Transmembrane prolyl 4-hydroxylaseHomo sapiens (human)IC50 (µMol)5.39335.18005.39335.5000AID160194; AID160197; AID226111
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (30)

Processvia Protein(s)Taxonomy
regulation of gene expressionLysine-specific demethylase 4EHomo sapiens (human)
chromatin remodelingLysine-specific demethylase 4EHomo sapiens (human)
collagen fibril organizationProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
regulation of cell growthProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN2Homo sapiens (human)
intracellular estrogen receptor signaling pathwayProlyl hydroxylase EGLN2Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN2Homo sapiens (human)
cell redox homeostasisProlyl hydroxylase EGLN2Homo sapiens (human)
positive regulation of protein catabolic processProlyl hydroxylase EGLN2Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaEgl nine homolog 1Homo sapiens (human)
intracellular iron ion homeostasisEgl nine homolog 1Homo sapiens (human)
intracellular oxygen homeostasisEgl nine homolog 1Homo sapiens (human)
negative regulation of DNA-binding transcription factor activityEgl nine homolog 1Homo sapiens (human)
regulation of angiogenesisEgl nine homolog 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEgl nine homolog 1Homo sapiens (human)
negative regulation of cyclic-nucleotide phosphodiesterase activityEgl nine homolog 1Homo sapiens (human)
cardiac muscle tissue morphogenesisEgl nine homolog 1Homo sapiens (human)
heart trabecula formationEgl nine homolog 1Homo sapiens (human)
ventricular septum morphogenesisEgl nine homolog 1Homo sapiens (human)
labyrinthine layer developmentEgl nine homolog 1Homo sapiens (human)
response to nitric oxideEgl nine homolog 1Homo sapiens (human)
regulation of modification of postsynaptic structureEgl nine homolog 1Homo sapiens (human)
regulation protein catabolic process at postsynapseEgl nine homolog 1Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineEgl nine homolog 1Homo sapiens (human)
cellular response to hypoxiaEgl nine homolog 1Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
DNA damage responseProlyl hydroxylase EGLN3Homo sapiens (human)
protein hydroxylationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of cell population proliferationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of erythrocyte differentiationTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
metal ion bindingLysine-specific demethylase 4EHomo sapiens (human)
histone H3K9me2/H3K9me3 demethylase activityLysine-specific demethylase 4EHomo sapiens (human)
histone H3K9 demethylase activityLysine-specific demethylase 4EHomo sapiens (human)
procollagen-proline 4-dioxygenase activityProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
iron ion bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
protein bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
L-ascorbic acid bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
identical protein bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN2Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN2Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
oxygen sensor activityProlyl hydroxylase EGLN2Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
protein bindingEgl nine homolog 1Homo sapiens (human)
ferrous iron bindingEgl nine homolog 1Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityEgl nine homolog 1Homo sapiens (human)
enzyme bindingEgl nine homolog 1Homo sapiens (human)
L-ascorbic acid bindingEgl nine homolog 1Homo sapiens (human)
peptidyl-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityEgl nine homolog 1Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN3Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN3Homo sapiens (human)
iron ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
calcium ion bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
L-ascorbic acid bindingTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
procollagen-proline 4-dioxygenase activityTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
nucleusLysine-specific demethylase 4EHomo sapiens (human)
nucleoplasmLysine-specific demethylase 4EHomo sapiens (human)
chromatinLysine-specific demethylase 4EHomo sapiens (human)
nucleusLysine-specific demethylase 4EHomo sapiens (human)
mitochondrionProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
endoplasmic reticulumProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
endoplasmic reticulum lumenProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
membraneProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
intracellular membrane-bounded organelleProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
procollagen-proline 4-dioxygenase complexProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
endoplasmic reticulumProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
cytosolEgl nine homolog 1Homo sapiens (human)
postsynaptic densityEgl nine homolog 1Homo sapiens (human)
intracellular membrane-bounded organelleEgl nine homolog 1Homo sapiens (human)
glutamatergic synapseEgl nine homolog 1Homo sapiens (human)
nucleusEgl nine homolog 1Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytosolProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
endoplasmic reticulum membraneTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
endoplasmic reticulumTransmembrane prolyl 4-hydroxylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (42)

Assay IDTitleYearJournalArticle
AID566700Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566706Inhibition of human recombinant MMP9 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID160198Compound was evaluated for the inhibition of prolyl 4-hydroxylase1992Journal of medicinal chemistry, Jul-10, Volume: 35, Issue:14
Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.
AID566704Inhibition of human recombinant MMP3 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566701Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566702Inhibition of human recombinant MMP1 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID659105Competitive inhibition of Streptococcus pneumoniae ASADH using aspartyl semialdehyde as substrate using Dixon plot analysis2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Molecular docking and enzymatic evaluation to identify selective inhibitors of aspartate semialdehyde dehydrogenase.
AID566707Inhibition of mouse recombinant iNOS at 1 mM after 40 mins by colorimetric assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID344922Inhibition of human collagene prolyl-3-hydroxylase2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID344924Inhibition of human recombinant HIF PHD32008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID323620Inhibition of Legionella gormani beta lactamase metallo FEZ1 expressed in Escherichia coli assessed as residual enzyme activity at 100 uM2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID1230195Inhibition of human human recombinant CP4H1 expressed in Escherichia coli Origami B(DE3) pre-incubated for 2 mins followed by alpha-ketoglutarate addition using dansylGlyProProGlyOEt substrate in Tris-HCl buffer at pH 7.8 at 30 degC by HPLC method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates.
AID323615Inhibition of Bacillus cereus metallo beta lactamase Bc2 assessed as residual enzyme activity at 100 uM2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID566703Inhibition of human recombinant MMP2 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID323614Inhibition of Pseudomonas aeruginosa 101/1477 metallo beta lactamase IMP1 expressed in in Escherichia coli assessed as residual enzyme activity at 100 uM in presence of zinc chloride2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID323618Inhibition of Aeromonas hydrophila metallo beta lactamase CphA assessed as residual enzyme activity at 100 uM in absence of zinc2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID160202Inhibitory activity against prolyl 4-hydroxylase1992Journal of medicinal chemistry, Jul-10, Volume: 35, Issue:14
Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.
AID344918Inhibition of 2-oxoglutarate-dependent human JMJD2E preincubated for 30 mins by FDH coupled assay2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID323626Inhibition of Aeromonas hydrophila beta lactamase CphA by competitive inhibition assay2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID344916Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID344914Inhibition of human recombinant PHD22008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID344921Inhibition of human collagene prolyl-4-hydroxylase2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID566705Inhibition of human recombinant MMP8 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID323619Inhibition of Stenotrophomonas maltophilia metallo beta lactamase L1 assessed as residual enzyme activity at 100 uM2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID323616Inhibition of metallo beta lactamase VIM2 assessed as residual enzyme activity at 100 uM2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID1230191Inhibition of human collagen prolyl 4-hydroxylase2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates.
AID1405296Inhibition of collagen prolyl 4-hydroxylase (unknown origin)2018Journal of medicinal chemistry, 12-13, Volume: 61, Issue:23
Collagen Prolyl 4-Hydroxylase as a Therapeutic Target.
AID323613Inhibition of Pseudomonas aeruginosa 101/1477 metallo beta lactamase IMP1 expressed in in Escherichia coli assessed as residual enzyme activity at 100 uM in absence of zinc2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID344923Inhibition of human recombinant HIF PHD12008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID566699Inhibition of mushroom tyrosinase at 1 mM after 10 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID323627Inhibition of Aeromonas hydrophila beta lactamase CphA N116H-N220G mutant by competitive inhibition assay2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID323617Inhibition of metallo beta lactamase VIM4 assessed as residual enzyme activity at 100 uM2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.
AID226111Inhibition of prolyl 4-hydroxylase by chromatographic determination of [14C]-succinic acid on ion-exchange minicolumna1993Journal of medicinal chemistry, Nov-26, Volume: 36, Issue:24
Novel inhibitors of prolyl 4-hydroxylase. 5. The intriguing structure-activity relationships seen with 2,2'-bipyridine and its 5,5'-dicarboxylic acid derivatives.
AID1230196Inhibition of human human recombinant CP4H1 expressed in Escherichia coli Origami B(DE3) pre-incubated for 2 mins followed by alpha-ketoglutarate addition using dansylGlyProProGlyOEt substrate in Tris-HCl buffer at pH 7.8 at 30 degC by HPLC based Cheng-Pr2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates.
AID1230194Inhibition of human human recombinant CP4H1 expressed in Escherichia coli Origami B(DE3) at 10 uM pre-incubated for 2 mins followed by alpha-ketoglutarate addition using dansylGlyProProGlyOEt substrate in Tris-HCl buffer at pH 7.8 at 30 degC by HPLC metho2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates.
AID160194Inhibition of prolyl 4-hydroxylase activity by an indirect assay1992Journal of medicinal chemistry, Mar-06, Volume: 35, Issue:5
Novel inhibitors of prolyl 4-hydroxylase. 2. 5-Amide substituted pyridine-2-carboxylic acids.
AID659106Competitive inhibition of Vibrio cholerae ASADH using aspartyl semialdehyde as substrate by Dixon plot analysis2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Molecular docking and enzymatic evaluation to identify selective inhibitors of aspartate semialdehyde dehydrogenase.
AID160197Inhibition of prolyl 4-hydroxylase1992Journal of medicinal chemistry, Mar-06, Volume: 35, Issue:5
Novel inhibitors of prolyl 4-hydroxylase.
AID1230198Inhibition of N-terminal hexa-histidine tagged human PHD2 (181 to 426 amino acids) at 10 uM pre-incubated for 2 mins followed by alpha-ketoglutarate addition using HIF1alpha peptide (556 to 574 amino acids) and 50 uM FeSO4 by RP-HPLC method2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Selective inhibition of prolyl 4-hydroxylases by bipyridinedicarboxylates.
AID344917Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
AID160196Inhibition of Prolyl 4-hydroxylase activity in cultured embryonic chick tendon cells; NA=Not active1992Journal of medicinal chemistry, Mar-06, Volume: 35, Issue:5
Novel inhibitors of prolyl 4-hydroxylase. 2. 5-Amide substituted pyridine-2-carboxylic acids.
AID1798635FDH Coupled Inhibition Assay from Article 10.1021/jm800936s: \\Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases.\\2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (9.09)18.7374
1990's6 (27.27)18.2507
2000's6 (27.27)29.6817
2010's6 (27.27)24.3611
2020's2 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.59 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]